https://doi.org/10.4081/hmr.v1i8.284

Chronic lymphocytic leukemia

Vol. 1 No. 8: New Drugs in Hematology, Bologna, October 9-11, 2005
Published: June 3, 2009
Abstract Views: 167
PDF: 362
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

MS Gentile
support@pagepress.org
A Guarini
FR Mauro
R Foà
Chronic lymphocytic leukemia (CLL) is a disorder characterized by a progressive accumulation of mature B lymphocytes which either avoid death because of external survival signals or go into apoptosis to be replenished by proliferating precursors. CLL is the most common type of leukemia of elderly people in the Western countries.1 Although the median survival is around 10 years, in individual patients the prognosis is extremely variable, ranging from a very short to a normal life span. After decades during which the wait and watch management has been the normal approach to these patients, the attitude of the physicians towards CLL patients has changed remarkably during the last few years. The reasons for this change are manifold and some are discussed below.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Gentile, M., Guarini, A., Mauro, F., & Foà, R. (2009). Chronic lymphocytic leukemia. Hematology Meeting Reports (formerly Haematologica Reports), 1(8). https://doi.org/10.4081/hmr.v1i8.284
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).